Pfizer DTC Ads For Celebrex Continue To Run
This article was originally published in The Pink Sheet Daily
Executive Summary
Winter-themed magazine ad will appear in the Feb. 1 issue of Real Simple, more than a month after Pfizer said it would halt its DTC campaign for the COX-2 inhibitor. A complete cessation of all ads is likely difficult due to the lead time needed for print publications.
You may also be interested in...
Pfizer's Celebrex, Bextra Ads Strike Wrong Chord With FDA
Agency cites COX-2 inhibitor promotions, including a reminder ad showing a guitarist playing "the long version" of a song thanks to Celebrex. The agency says the violations would have warranted a warning letter if not for Pfizer's previous agreement to halt Celebrex advertising.
Pfizer's Celebrex, Bextra Ads Strike Wrong Chord With FDA
Agency cites COX-2 inhibitor promotions, including a reminder ad showing a guitarist playing "the long version" of a song thanks to Celebrex. The agency says the violations would have warranted a warning letter if not for Pfizer's previous agreement to halt Celebrex advertising.
Celebrex New Year's Resolution Is Final Spot Before DTC Hibernation
The ad ran in the Dec. 19 New York Times Magazine, the day before FDA announced that Pfizer had agreed to halt DTC ads. The ad features cartoon characters making snow angels under the statement "Arthritis pain? Bah, Humbug!"